Bioharvest Sciences Inc. (BHST)
BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Lags Revenue Estimates
BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.16 per share a year ago.
BioHarvest sciences posts Q3 revenue rise, launches new hydration product
BioHarvest Sciences Inc. (NASDAQ:BHST), a biotechnology company known for its patented Botanical Synthesis technology, reported a 39% increase in third-quarter revenue, driven by growth in its core VINIA capsule business and expanding contract development and manufacturing (CDMO) operations. Total revenues for the quarter ended September 30 rose to $9.1 million, in line with management guidance.
BioHarvest Sciences raises $19.9M in public offering to fund expansion
BioHarvest Sciences Inc. (NASDAQ:BHST), a company developing its patented Botanical Synthesis technology platform, said on Monday it has completed an underwritten public offering of 2.85 million shares of common stock at $7 per share, generating gross proceeds of $19.9 million. The company said it plans to use the net proceeds for manufacturing expansion, research and development, marketing, debt reduction or refinancing, other capital expenditures, and general corporate purposes, including working capital.
BioHarvest Sciences to raise $17.4M in upsized public equity offering
BioHarvest Sciences Inc. (NASDAQ:BHST) announced that it has priced its underwritten public offering of 2,485,000 company shares at $7.00 per share, for expected gross proceeds of about $17.4 million. The company said it expects to use the net proceeds from the offering for research and development, manufacturing, marketing, advancing the CDMO business unit, debt reduction or debt refinancing, capital expenditures, and general corporate purposes, including funding working capital.
BioHarvest Sciences CEO discusses Saffron Tech partnership - ICYMI
BioHarvest Sciences Inc. (NASDAQ:BHST) CEO Ilan Sobel talked with Proactive about the company's new partnership with Saffron Tech aimed at developing a high-value saffron-based nutraceutical. Sobel explained that Saffron Tech, an Israeli firm, has pioneered an indoor horticultural system for growing first-grade saffron — known as "red gold" — which retails for up to $10,000 per kilo.
BioHarvest Sciences Inc. (BHST) Virtual Investor Webinar Call (Transcript)
BioHarvest Sciences Inc. (NASDAQ:BHST ) Virtual Investor Webinar Conference September 10, 2025 01:00 PM ET Company Participants Ilan Sobel - Chief Executive Officer Zaki Rakib - Co-Founder, Executive Chairman & President Conference Call Participants Nicholas Sherwood - Maxim Group LLC, Research Division Hunter Diamond - Diamond Equity Research LLC Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division Alec Legg - Canaccord Genuity Corp., Research Division Robert LeBoyer - NOBLE Capital Markets, Inc., Research Division Presentation Operator Good day, and welcome to the BioHarvest Sciences Virtual Investor Webinar. Today's webinar is being recorded.
BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates
BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.04 per share a year ago.
BioHarvest Sciences Inc. (BHST) Q2 2025 Earnings Call Transcript
BioHarvest Sciences Inc. (NASDAQ:BHST ) Q2 2025 Earnings Conference Call August 11, 2025 8:00 AM ET Company Participants Bar Dichter - Chief Financial Officer Ilan Sobel - Chief Executive Officer Conference Call Participants Amit Dayal - H.C. Wainwright & Co, LLC, Research Division Anthony V.
BioHarvest Sciences Q2 revenue jumps on VINIA growth
BioHarvest Sciences Inc. (NASDAQ:BHST) reported a 41% rise in second-quarter revenue, driven by growth in its VINIA product line and contributions from its contract development and manufacturing (CDMO) business. Revenue for the quarter ended June 30 rose to $8.5 million from $6 million a year earlier, in line with the company's guidance.
BioHarvest Sciences Inc. (BHST) Surges 5.6%: Is This an Indication of Further Gains?
BioHarvest Sciences Inc. (BHST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BioHarvest Sciences launches Informed Sport-certified daily chew - ICYMI
BioHarvest Sciences Inc. (NASDAQ:BHST) CEO Ilan Sobel talked with Proactive about the company's newest addition to its Vinia product line, a daily “2X formula” chew, specifically designed for athletes and highly active consumers. The chew delivers 12mg of Piceid Resveratrol, doubling the dose found in the original capsule format.
BioHarvest Sciences launches Informed Sport-certified VINIA DailyChews 2X Formula
BioHarvest Sciences Inc. (NASDAQ:BHST) has launched a new product tailored to athletes and individuals with active lifestyles called VINIA DailyChews 2X Formula. The developer of botanical-based wellness products using its proprietary Botanical Synthesis said this new product is now available for purchase in a 30-count pack through VINIA.com.
